Internal Medicine, Rheumatology · Austin, TX
NPI
1285684803
Since 2006
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
6811 Austin Center Blvd., #300
Austin, TX, 78731
Phone (512) 346-8888
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.3M
98,599 services
Medicare patients, 2024
366
Average age 73
Drug cost, 2024
$1.8M
2,911 prescriptions
Company payments, 2025
$702
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Tina C Bunch was code J0717 (injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)), 40,400 times for 12 patients. In total Tina C Bunch billed 98,599 services in 110 codes, and Medicare paid $1.3M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-11-08.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| J0717 Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 40,400 | 12 | $3.61 | $146K |
| J1602 Injection, golimumab, 1 mg, for intravenous use | Office | 16,000 | 18 | $9.06 | $145K |
| J0897 Injection, denosumab, 1 mg | Office | 9,900 | 99 | $20.52 | $203K |
| 99214 Office E&M - Established | Office | 505 | 289 | $88.58 | $45K |
| 96401 Chemotherapy Administration | Office | 438 | 112 | $57.77 | $25K |
| 80053 Clinical Chemistry | Office | 414 | 244 | $10.27 | $4,250 |
| 85025 Blood Count | Office | 316 | 161 | $7.52 | $2,376 |
| 96413 Chemotherapy Administration | Office | 252 | 36 | $104.42 | $26K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 250 | 187 | $11.08 | $2,771 |
| 86140 Clinical Chemistry | Office | 207 | 106 | $5.02 | $1,038 |
| J3489 Injection, zoledronic acid, 1 mg | Office | 200 | 40 | $4.33 | $867 |
| 85652 Clinical Chemistry | Office | 188 | 101 | $2.62 | $493 |
| 82306 Clinical Chemistry | Office | 179 | 157 | $29.01 | $5,193 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 88 | 19 | $0.73 | $64.43 |
| 99204 Office E&M - New | Office | 84 | 84 | $115.76 | $9,724 |
By year: 2022 $1.0M for 85,023 services; 2023 $969K for 81,948 services; 2024 $1.3M for 98,599 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80053 Clinical Chemistry | 414 | 244 | $10.27 | $4,250 |
| 85025 Blood Count | 316 | 161 | $7.52 | $2,376 |
| 86140 Clinical Chemistry | 207 | 106 | $5.02 | $1,038 |
| 85652 Clinical Chemistry | 188 | 101 | $2.62 | $493 |
| 82306 Clinical Chemistry | 179 | 157 | $29.01 | $5,193 |
| 84443 Clinical Chemistry | 58 | 55 | $16.24 | $942 |
| 84550 Clinical Chemistry | 50 | 37 | $4.36 | $218 |
| 86480 Immunoassay | 27 | 27 | $59.72 | $1,612 |
| 83036 Blood Count | 21 | 20 | $9.14 | $192 |
| 86200 Immunoassay | 20 | 20 | $12.32 | $246 |
Medicare prescription drug claims, 2024
In 2024, the drug Tina C Bunch prescribed most often to Medicare patients was Methotrexate (Methotrexate Sodium), with 398 prescriptions and refills. In total Tina C Bunch wrote 2,911 Medicare prescriptions that cost $1.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Methotrexate Methotrexate Sodium | 398 | 1,027 | 125 | $11K |
| Hydroxychloroquine Sulfate Generic | 309 | 886 | 101 | $9,806 |
| Meloxicam Generic | 232 | 640 | 95 | $1,536 |
| Allopurinol Generic | 225 | 649 | 70 | $2,893 |
| Prednisone Generic | 198 | 383 | 82 | $1,306 |
| Gabapentin Generic | 162 | 444 | 64 | $3,304 |
| Celecoxib Generic | 131 | 334 | 52 | $7,570 |
| Tramadol Hcl Generic | 97 | 111 | 20 | $560 |
| Cevimeline Hcl Generic | 94 | 238 | 40 | $23K |
| Alendronate Sodium Generic | 88 | 231 | 38 | $739 |
| Enbrel Sureclick Etanercept | 78 | 85 | Under 11 | $628K |
| Leflunomide Generic | 67 | 147 | 17 | $4,595 |
| Duloxetine Hcl Generic | 56 | 161 | 18 | $1,243 |
| Folic Acid Generic | 44 | 130 | 17 | $409 |
| Naproxen Generic | 36 | 105 | 15 | $636 |
Brand drugs: - claims; generic drugs: 2,560 claims; opioid claims: 135.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Tina C Bunch $702 ($702 in general payments such as food, travel and fees) from 4 companies. The largest payer was Janssen Biotech, Inc. with $293.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.